Vanguard Group
GOSS icon

Vanguard Group’s Gossamer Bio GOSS Stock Holding History

Vanguard Group’s Portfolio GOSS Stock Details GOSS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		$39.9M Buy
160,915
+10,793
+7% +$2.46M ﹤0.01% 2292
2025
Q3 		$31.6M Buy
150,122
+7,487
+5% +$1.32M ﹤0.01% 2395
2025
Q2 		$14M Buy
142,635
+16,586
+13% +$1.45M ﹤0.01% 2733
2025
Q1 		$11.1M Buy
126,049
+622
+0.5% +$57.5K ﹤0.01% 2786
2024
Q4 		$9.08M Sell
125,427
-21,503
-15% -$1.47M ﹤0.01% 3007
2024
Q3 		$11.6M Sell
146,930
-73
-0% -$5.62K ﹤0.01% 2886
2024
Q2 		$10.6M Sell
147,003
-44
-0% -$2.63K ﹤0.01% 2879
2024
Q1 		$13.9M Buy
147,047
+1,602
+1% +$141K ﹤0.01% 2779
2023
Q4 		$10.6M Buy
145,445
+4,591
+3% +$271K ﹤0.01% 2911
2023
Q3 		$9.38M Buy
140,854
+96,078
+215% +$8.86M ﹤0.01% 2922
2023
Q2 		$4.3M Sell
44,776
-37,096
-45% -$3.7M ﹤0.01% 3378
2023
Q1 		$8.25M Sell
81,872
-17,626
-18% -$2.7M ﹤0.01% 3045
2022
Q4 		$17.3M Buy
99,498
+7,671
+8% +$5.05M ﹤0.01% 2690
2022
Q3 		$88M Buy
91,827
+18,673
+26% +$18.5M ﹤0.01% 1871
2022
Q2 		$49M Buy
73,154
+2,470
+3% +$1.53M ﹤0.01% 2202
2022
Q1 		$49.1M Buy
70,684
+841
+1% +$649K ﹤0.01% 2317
2021
Q4 		$63.2M Buy
69,843
+1,108
+2% +$1.05M ﹤0.01% 2223
2021
Q3 		$69.1M Buy
68,735
+822
+1% +$605K ﹤0.01% 2185
2021
Q2 		$44.1M Buy
67,913
+641
+1% +$445K ﹤0.01% 2447
2021
Q1 		$49.8M Buy
67,272
+299
+0.4% +$241K ﹤0.01% 2321
2020
Q4 		$51.8M Buy
66,973
+8,097
+14% +$6.38M ﹤0.01% 2184
2020
Q3 		$58.5M Sell
58,876
-2,151
-4% -$2.28M ﹤0.01% 1930
2020
Q2 		$63.5M Buy
61,027
+13,374
+28% +$13.5M ﹤0.01% 1881
2020
Q1 		$38.7M Buy
47,653
+1,090
+2% +$1.14M ﹤0.01% 1985
2019
Q4 		$58.2M Sell
46,563
-5,324
-10% -$8.58M ﹤0.01% 2035
2019
Q3 		$69.7M Buy
51,887
+31,540
+155% +$50.2M ﹤0.01% 1922
2019
Q2 		$36.1M Buy
20,347
+3,189
+19% +$4.88M ﹤0.01% 2268
2019
Q1 		$29.7M Buy
+17,158
New +$28.6M ﹤0.01% 2326

Other funds holding GOSS

NMC
NEA Management Company Timonium, Maryland $1.59B AUM 234.06% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
OCA
Octagon Capital Advisors New York $1.11B AUM 866.76% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
AVM
Arch Venture Management Chicago, Illinois $1.1B AUM 356.62% 1-Year Est. Return
SB
Samsara BioCapital Palo Alto, California $1.22B AUM 242.83% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $4.94B AUM 244.43% 1-Year Est. Return
6CM
683 Capital Management New York $2.04B AUM 94.26% 1-Year Est. Return
HA
HHLR Advisors Grand Cayman, Cayman Islands $832M AUM 32.38% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Vanguard Group's GOSS Position: Q4 2025 in Review

Vanguard Group increased its Gossamer Bio (GOSS) stake by 7.2% in Q4 2025, buying an estimated $2.46M and bringing the position to 160,915 shares worth $39.9M. The position accounts for ﹤0.01% of the portfolio, ranked #2292.

Vanguard Group first reported a position in GOSS in Q1 2019 and has held it in 28 quarters since. The position peaked at $88M in Q3 2022. 192 funds tracked by Wall St. Rank hold GOSS as of Q4 2025.

  • Vanguard Group held 160,915 shares of Gossamer Bio worth $39.9M as of Q4 2025.
  • Vanguard Group bought 10,793 Gossamer Bio shares in Q4 2025, an estimated $2.46M.
  • Gossamer Bio made up ﹤0.01% of Vanguard Group's portfolio in Q4 2025, its #2292 holding.
  • Vanguard Group first reported a position in Gossamer Bio in Q1 2019 and has held it in 28 quarters since.
  • Vanguard Group's Gossamer Bio position peaked at $88M in Q3 2022.
  • 192 funds tracked by Wall St. Rank held Gossamer Bio as of Q4 2025.

Based on Vanguard Group's 13F filing for Q4 2025, filed 29 Jan 2026.